Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Flagstar Bank NA (FLG) Price & Performance

Abeona Therapeutics IncTrade
Flagstar Bank NATrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Flagstar Bank NA — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Flagstar Bank NA trades at $14.23 (market cap $5.89B). The key difference: Flagstar Bank NA is far larger — about 14× Abeona Therapeutics Inc's market cap, and Flagstar Bank NA pays a 0.28% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOFLG
Market Cap
$421.19M$5.89B
Sector
HealthFinancials
52-Week High
$7.45$15.36
52-Week Low
$4.17$10.72
Enterprise Value
$276.10M
Dividend Yield
0.28%

Returns comparison

Trailing returns across standard periods

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Flagstar Bank NA

Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.

Read more on FLG